Hashish enterprise
France's three-year medical hashish pilot program formally got here to an finish final week (March 26) because the scheme moved into its “transition interval” earlier than full generalization, which is because of be launched no later than from January 1, 2025.
This transition interval is designed to supply “continuity of remedy” for sufferers at the moment accessing free hashish medicines by way of the pilot scheme, whereas permitting the federal government time to work out the small print of what is going to be full mainstreaming. .
As Hashish enterprise reported final month, the French Nationwide Company for the Security of Medicines (ANSM) confirmed that the flowers is not going to be included within the common framework of medical hashish, forcing about 100 sufferers to change to another remedy.
The transfer has additionally come as a disappointment to many European hashish companies, who might be keenly conscious of the dominance of medical hashish flowers in markets throughout Europe.
Whereas many questions stay as to what this everlasting system might be, extra particulars of the incoming transition interval are starting to emerge.
The federal government has printed formal particulars concerning the circumstances, costs and registered merchandise of the transition interval.
Within the decree printed on March 28 within the “Legal guidelines and Decrees of the Official Journal”, the costs for the six out there merchandise “used throughout the transition part” have been listed.
Learn extra
https://businessofcannabis.com/germanys-cang-comes-into-effect-frances-medical-cannabis-pilot-officially-ends-jersey-signals-potential-crackdown-on-prescriptions/
